<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00890695</url>
  </required_header>
  <id_info>
    <org_study_id>SSC 1415</org_study_id>
    <nct_id>NCT00890695</nct_id>
  </id_info>
  <brief_title>Effectiveness of Supplementary Feeding During Infection Among Moderately Malnourished Children</brief_title>
  <acronym>MODMAL</acronym>
  <official_title>Randomized Controlled Trial of an Outpatient Strategy of Ready to Use Supplementary Food (RUSF) Among Moderately Malnourished Children With Acute Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an outpatient-based strategy of short-term,
      ready to use supplementary food (RUSF) among moderately malnourished children with acute
      infections achieves greater improvement in anthropometric measurements of wasting than usual
      diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Under nutrition is a contributing factor to at least a third of child deaths. Whilst severe
      malnutrition has the highest mortality risk, most malnutrition-related deaths are thought to
      be related to mild-moderate malnutrition.This is because moderate malnutrition is common, it
      directly increases the risk of death from common infectious diseases and may progress to
      severe malnutrition.

      Malnutrition may arise from poverty, food insecurity or inadequate nutrition being offered,
      and may begin early in life. Malnutrition is exacerbated by the multiple effects of
      infectious diseases such as gastroenteritis, pneumonia, malaria or HIV. All these common
      infections are associated with net protein loss with diversion of essential amino acids to
      producing acute phase and immune response proteins. Fever is associated with an increased
      resting energy expenditure of 7 to 13% per degree Centigrade. Activation of inflammatory
      cascades also causes reduced appetite and loss of lean tissue and fat. Acute infection is
      therefore associated with growth faltering, resulting in a vicious cycle. Acute infection is
      therefore a potential target for intervention to interrupt the vicious cycle between
      malnutrition and infection in children.

      This study aims to evaluate a strategy of giving short-term RUSF as a supplement to usual
      diet at home, without daily observed feeding, administered through existing health services
      at Kilifi District Hospital, Kenya. RUSF has a very low moisture content and is essentially a
      lipid-enveloped paste, it is microbiologically stable with a long shelf life at tropical
      temperatures and preserves delicate micronutrients such as vitamin A.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    New provision of supplementary feeds for moderately malnourished children
  </why_stopped>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open label randomised trial of nutrition products</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight for Height z Score at 4 Weeks</measure>
    <time_frame>between enrolment and 4 weeks</time_frame>
    <description>The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition.
A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ&lt;-2 and &lt;-3 respectively. These correspond to 2 and 3 standard deviations below the reference median.
Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WHZ Score at 3 Months</measure>
    <time_frame>between enrolment and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MUAC for Age Z Score at 3 Months</measure>
    <time_frame>between enrolment and 4 weeks and at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of Severe Malnutrition (WHZ Score &lt;-3 and/or Kwashiorkor)</measure>
    <time_frame>at 4 weeks and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anemia (Hb &lt;9.3g/dl)</measure>
    <time_frame>at 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Admission or Death</measure>
    <time_frame>from enrolment to 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Malnutrition</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Ready to use supplementary food (RUSF)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The RUSF intervention consists of a food paste made of maize, soya, sorghum, vegetable oil, sugar, dried skim milk and vitamin/mineral premix, prepared by VALID Nutrition in collaboration with Insta Products, Kenya in accordance with composition specified by the latest WHO expert consultation in 2008. Children in the intervention arm receive 4 weeks supply of RUSF. The amount supplied is based on the child's weight to give energy supplement of 100kcal per kg per day, equivalent to 25g RUSF per kg per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal diet (standard of care)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>For equity, parents or guardians of children in the usual diet arm will be given 2 bags of maize meal(4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ready to use supplementary food (RUSF)</intervention_name>
    <description>It is a strategy of detection of moderate malnutrition and providing advice and short term provision of a standard formulation of ready to use supplementary food (RUSF) for 4 weeks with appropriate counseling on its use.The amount supplied will be based on the child's weight; 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.</description>
    <arm_group_label>Ready to use supplementary food (RUSF)</arm_group_label>
    <other_name>RUSF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 6 months to 5 years

          -  Mid-upper arm circumference (MUAC) less than 12.5 cm

          -  Resident in the Kilifi demographic surveillance (DSS) area

          -  Presentation with acute (&lt;5 days) illness including respiratory infection, malaria,
             diarrhoeal disease or other acute infection.

          -  If admitted, admission of &lt;5 days, recruited at discharge.

        Exclusion Criteria:

          -  Severe malnutrition (WHZ score &lt; -3 or Kwashiorkor)

          -  Requiring admission to hospital in the opinion of clinician

          -  Known allergy to maize, soya, sorghum, milk or any RUSF components.

          -  Consent declined

          -  Underlying condition precluding assessment or inclusion

          -  Any other reason why the consenting investigator thinks it is not appropriate for them
             to take part.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James A Berkley</last_name>
    <role>Principal Investigator</role>
    <affiliation>KEMRI-Wellcome Trust Collaborative Research Program</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kemri Wellcome Trust Research Programme</name>
      <address>
        <city>Kilifi</city>
        <state>Coast Province</state>
        <zip>80108</zip>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kilifi District Hospital- OPD</name>
      <address>
        <city>Kilifi</city>
        <state>Coast</state>
        <zip>80108</zip>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2009</study_first_submitted>
  <study_first_submitted_qc>April 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2009</study_first_posted>
  <results_first_submitted>January 15, 2013</results_first_submitted>
  <results_first_submitted_qc>June 17, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 19, 2013</results_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oxford</investigator_affiliation>
    <investigator_full_name>James Berkley</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>supplementary feeding</keyword>
  <keyword>moderate malnutrition</keyword>
  <keyword>acute infection</keyword>
  <keyword>developing country</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment was started on June 5 2009 and finished on October 8 2009. The study was terminated early because of an inadequate recruitment rate and because a donor-funded supplementary feeding programme targeting moderately malnourished children was started in September 2009.</recruitment_details>
      <pre_assignment_details>Of the 7,132 sick children aged 6 months to 5 years seen in outpatients during the study period, 190 with a mid upper arm circumference (MUAC) &lt;12.5cm were assessed for eligibility. Randomization was carried out on 65 children who were eligible and whose carers consented. 1 was withdrawn: weight for height Z score (WHZ) was found to be &lt;-3.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>1 Ready to Use Supplementary Food (RUSF)</title>
          <description>Products, Kenya. The RUSF composition is in accordance with recommended supplementary feed composition specified by the latest WHO expert consultation in 2008 reported by Golden et al. It is formulated to provide 507 kcal per 100g, 6% protein/energy ratio and 55% fat/energy ratio. Essential fatty acids contained are N-6 (linoleic acid) 6 kcal % and N-3 (o-linoleic) 0.3 kcal %. Vitamin and mineral premix (3%) will provide the currently recommended nutrient intake for moderately malnourished children of minerals (K, Na, Ca, P, Mg, Fe, Zn, Cu, Se, I, Mn, Cr, Mo, F), Vitamins (thiamine, riboflavin, pyridoxine, niacin, Vit B12, folic acid, Vit C, Biotin, Pantothenic acid, Vit A, Vit D,Vit E and Vit K).
initial visit. The amount supplied is based on the child's weight; the recommended energy supplement being 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.</description>
        </group>
        <group group_id="P2">
          <title>2 Normal Diet</title>
          <description>For equity, parents or guardians of children in the usual diet arm are given 2 bags of maize meal (4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 RUSF</title>
          <description>RUSF prescribed for the child for 4 weeks</description>
        </group>
        <group group_id="B2">
          <title>2 Normal Diet</title>
          <description>normal diet arm</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="64"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.21" spread="0.55"/>
                    <measurement group_id="B2" value="1.15" spread="0.46"/>
                    <measurement group_id="B3" value="1.18" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Kenya</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight for Height z Score at 4 Weeks</title>
        <description>The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition.
A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ&lt;-2 and &lt;-3 respectively. These correspond to 2 and 3 standard deviations below the reference median.
Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.</description>
        <time_frame>between enrolment and 4 weeks</time_frame>
        <population>All participants recruited until trial was halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>Weight for Height z Score at 4 Weeks</title>
          <description>The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition.
A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ&lt;-2 and &lt;-3 respectively. These correspond to 2 and 3 standard deviations below the reference median.
Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.</description>
          <population>All participants recruited until trial was halted</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.83" lower_limit="-2.15" upper_limit="-1.51"/>
                    <measurement group_id="O2" value="-1.44" lower_limit="-1.65" upper_limit="-1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>WHZ Score at 3 Months</title>
        <time_frame>between enrolment and 3 months</time_frame>
        <population>All participants recruited until trial halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>WHZ Score at 3 Months</title>
          <population>All participants recruited until trial halted</population>
          <units>Z scores</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.43" lower_limit="-1.68" upper_limit="-1.18"/>
                    <measurement group_id="O2" value="-1.29" lower_limit="-1.56" upper_limit="-1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MUAC for Age Z Score at 3 Months</title>
        <time_frame>between enrolment and 4 weeks and at 3 months</time_frame>
        <population>All participants recruited until trial halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>MUAC for Age Z Score at 3 Months</title>
          <population>All participants recruited until trial halted</population>
          <units>Z score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.71" lower_limit="-1.99" upper_limit="-1.43"/>
                    <measurement group_id="O2" value="-1.62" lower_limit="-1.95" upper_limit="-1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Development of Severe Malnutrition (WHZ Score &lt;-3 and/or Kwashiorkor)</title>
        <time_frame>at 4 weeks and 3 months</time_frame>
        <population>All participants recruited until trial halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>Development of Severe Malnutrition (WHZ Score &lt;-3 and/or Kwashiorkor)</title>
          <population>All participants recruited until trial halted</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anemia (Hb &lt;9.3g/dl)</title>
        <time_frame>at 4 weeks</time_frame>
        <population>All participants recruited until trial halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>Anemia (Hb &lt;9.3g/dl)</title>
          <population>All participants recruited until trial halted</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Admission or Death</title>
        <time_frame>from enrolment to 3 months</time_frame>
        <population>All participants recruited until trial halted</population>
        <group_list>
          <group group_id="O1">
            <title>1 RUSF</title>
            <description>RUSF prescribed for the child for 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>2 Normal Diet</title>
            <description>normal diet arm</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Admission or Death</title>
          <population>All participants recruited until trial halted</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>1 RUSF</title>
          <description>RUSF prescribed for the child for 4 weeks</description>
        </group>
        <group group_id="E2">
          <title>2 Normal Diet</title>
          <description>normal diet arm</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Severe malnutrition</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="31"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="31"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The trial was forced to stop early, 65 recruited. Analysis was inadequately powered to detect the changes in WHZ score and MUAC, the analysis of which had been originally planned for a sample size of 400.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr James Berkley</name_or_title>
      <organization>KEMRI/Wellcome Trust Research Programme</organization>
      <phone>+254 41 522535</phone>
      <email>jberkley@kilifi.kemri-wellcome.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

